Spanish Red Biotech Pipeline

Dobecure

Ethamsylate

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: Rendu-Osler-Weber syndrome or Hereditary Hemorrhagic Telangiectasia (HHT)
Phase: 3Phase III, 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical